Literature DB >> 2247800

Sexually transmitted diseases and tubal pregnancy.

K J Sherman1, J R Daling, A Stergachis, N S Weiss, H M Foy, S P Wang, J T Grayston.   

Abstract

The risk of tubal pregnancy associated with seropositivity to Chlamydia trachomatis or following a diagnosis of gonorrhea, genital herpes, trichomoniasis, genital warts, or nonspecific vaginal infection was evaluated in a study of this condition among women who were members of a prepaid health plan. A total of 264 women who had a tubal pregnancy between 1981 and 1986 were interviewed about their history of these sexually transmitted diseases (STDs). Their responses were compared to those of 715 women who were matched by age and county of residence but were otherwise randomly selected from the enrollment files of the health plan. Chlamydia antibody status was known in a sample of 135 cases and 192 controls. Although more cases reported a history of gonorrhea, trichomoniasis, and non-specific vaginal infections than did controls, only a modestly elevated risk for trichomoniasis remained after logistic regression was used to adjust for the effects of age, reference year, race, presence of contraception at reference date, seropositivity to Chlamydia trachomatis, and a history of other STDs. By contrast, among women for whom Chlamydia trachomatis antibody status was assessed, presence of antibody was associated with a two-fold increase in the risk of tubal pregnancy after adjusting for the effects of the previously enumerated variables. These findings confirm the relevance of Chlamydia trachomatis as a risk factor for ectopic pregnancy, and they also underscore the importance of adjustment for the influence of other STDs when evaluating the association between a specific STD and the occurrence of tubal pregnancy.

Entities:  

Mesh:

Year:  1990        PMID: 2247800     DOI: 10.1097/00007435-199007000-00001

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  42 in total

1.  Protective immunity against mouse upper genital tract pathology correlates with high IFNγ but low IL-17 T cell and anti-secretion protein antibody responses induced by replicating chlamydial organisms in the airway.

Authors:  Chunxue Lu; Hao Zeng; Zhihong Li; Lei Lei; I-Tien Yeh; Yimou Wu; Guangming Zhong
Journal:  Vaccine       Date:  2011-11-10       Impact factor: 3.641

2.  Localization and characterization of GTP-binding protein CT703 in the Chlamydia trachomatis-Infected cells.

Authors:  Kun Du; Fuyan Wang; Zhi Huo; Jie Wang; Wen Cheng; Ming Li; Ping Yu
Journal:  Curr Microbiol       Date:  2010-08-20       Impact factor: 2.188

3.  A chlamydial type III-secreted effector protein (Tarp) is predominantly recognized by antibodies from humans infected with Chlamydia trachomatis and induces protective immunity against upper genital tract pathologies in mice.

Authors:  Jie Wang; Lili Chen; Fan Chen; Xiaoyun Zhang; Yingqian Zhang; Joel Baseman; Sondra Perdue; I-Tien Yeh; Rochelle Shain; Martin Holland; Robin Bailey; David Mabey; Ping Yu; Guangming Zhong
Journal:  Vaccine       Date:  2009-03-10       Impact factor: 3.641

4.  The chlamydial plasmid-encoded protein pgp3 is secreted into the cytosol of Chlamydia-infected cells.

Authors:  Zhongyu Li; Ding Chen; Youmin Zhong; Shiping Wang; Guangming Zhong
Journal:  Infect Immun       Date:  2008-05-12       Impact factor: 3.441

5.  Chlamydia trachomatis secretion of hypothetical protein CT622 into host cell cytoplasm via a secretion pathway that can be inhibited by the type III secretion system inhibitor compound 1.

Authors:  Siqi Gong; Lei Lei; Xiaotong Chang; Robert Belland; Guangming Zhong
Journal:  Microbiology (Reading)       Date:  2011-01-13       Impact factor: 2.777

6.  Mortality related to sexually transmitted diseases in US women, 1973 through 1992.

Authors:  S H Ebrahim; T A Peterman; A A Zaidi; M L Kamb
Journal:  Am J Public Health       Date:  1997-06       Impact factor: 9.308

7.  Complement factor C5 but not C3 contributes significantly to hydrosalpinx development in mice infected with Chlamydia muridarum.

Authors:  Zhangsheng Yang; Turner Conrad; Zhou Zhou; Jianlin Chen; Pavel Dutow; Andreas Klos; Guangming Zhong
Journal:  Infect Immun       Date:  2014-05-19       Impact factor: 3.441

8.  Chlamydia-infected cells continue to undergo mitosis and resist induction of apoptosis.

Authors:  Whitney Greene; Yangming Xiao; Yanqing Huang; Grant McClarty; Guangming Zhong
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

9.  Signaling via tumor necrosis factor receptor 1 but not Toll-like receptor 2 contributes significantly to hydrosalpinx development following Chlamydia muridarum infection.

Authors:  Xiaohua Dong; Yuanjun Liu; Xiaotong Chang; Lei Lei; Guangming Zhong
Journal:  Infect Immun       Date:  2014-02-18       Impact factor: 3.441

10.  Transformation of Chlamydia muridarum reveals a role for Pgp5 in suppression of plasmid-dependent gene expression.

Authors:  Yuanjun Liu; Chaoqun Chen; Siqi Gong; Shuping Hou; Manli Qi; Quanzhong Liu; Joel Baseman; Guangming Zhong
Journal:  J Bacteriol       Date:  2013-12-20       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.